APRE short interest
Aprea Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 508,841 |
|---|---|
| Change vs prior report | -65,764 (-11.4%) |
| Change over six months | -20.5% |
| Days to cover | 2.45 (sector: 3.78) |
| Average daily volume | 207,556 |
| Rank in Healthcare | #682 of 922 by days to cover |
APRE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 508,841 | -11.4% | 2.45 | 207,556 |
| 2026-09-15 | 574,605 | -6.8% | 3.24 | 177,428 |
| 2026-08-31 | 616,887 | +11142.7% | 1.00 | 893,115 |
| 2026-08-14 | 5,487 | -86.6% | 1.00 | 46,742 |
| 2026-07-31 | 41,083 | -32.2% | 1.00 | 47,642 |
| 2026-07-15 | 60,595 | -22.1% | 1.00 | 74,736 |
| 2026-06-30 | 77,797 | +22.5% | 1.00 | 100,138 |
| 2026-06-15 | 63,530 | -46.6% | 1.00 | 126,040 |
| 2026-05-29 | 119,012 | -19.4% | 1.00 | 148,030 |
| 2026-05-15 | 147,564 | +43.2% | 1.00 | 224,819 |
| 2026-04-30 | 103,019 | -6.3% | 1.00 | 264,571 |
| 2026-04-15 | 109,910 | -82.8% | 1.00 | 410,244 |
| 2026-03-31 | 640,347 | +500.4% | 1.00 | 832,163 |
| 2026-03-13 | 106,655 | -56.6% | 1.01 | 105,670 |
| 2026-02-27 | 245,983 | -3.5% | 1.00 | 637,902 |
| 2026-02-13 | 255,047 | -1.9% | 1.00 | 563,996 |
| 2026-01-30 | 260,110 | +623.6% | 1.00 | 11,506,003 |
| 2026-01-15 | 35,947 | +0.9% | 1.00 | 86,355 |
| 2025-12-31 | 35,625 | +3.0% | 1.00 | 53,836 |
| 2025-12-15 | 34,578 | -41.3% | 1.00 | 100,933 |
| 2025-11-28 | 58,925 | -6.9% | 1.68 | 35,046 |
| 2025-11-14 | 63,277 | -9.0% | 1.00 | 96,786 |
| 2025-10-31 | 69,543 | +39.5% | 1.00 | 184,290 |
| 2025-10-15 | 49,837 | -42.3% | 1.00 | 67,423 |
| 2025-09-30 | 86,411 | +1.6% | 2.03 | 42,471 |
import finzdata as yf
yf.Ticker("APRE").short_interest # every report since 2017
yf.Client().short_interest(["APRE"], start="2018-01-01")Healthcare short interest · APRE price history · Who owns APRE · All short interest